Notifier les effets indésirables : pourquoi et comment ?

Lescrainier, Cécile;Beuken, Guy;Roisin, Thierry;Hamdani, Jamila
(2013) La Revue de la Médecine Générale — Vol. 302, p. 32-40 (2013)

Files

2013_Lescrainier_RMG.pdf
  • Open Access
  • Adobe PDF
  • 1.85 MB
Download

Details

Authors
  • Lescrainier, Cécile
    Author
  • Beuken, GuyUCLouvain
    Author
  • Roisin, ThierryUCLouvain
    Author
  • Hamdani, JamilaUCLouvain
    Author
Abstract
(en) Adverse drug reactions potentially related to drugs are a major issue in public health. Only 1-5% of adverse effects are reported to pharmacovigilance centers and yet the notification is part of the evaluation of the risk benefit balance of drugs and should be incorporated into clinical practice.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Lescrainier, C., Beuken, G., Roisin, T., & Hamdani, J. (2013). Notifier les effets indésirables : pourquoi et comment ? La Revue de la Médecine Générale, 302, 32-40. https://hdl.handle.net/2078.5/109845 (Original work published 2013)